Pilot BE
When Should We Not Skip a Pilot BE Study?
In generic development, we often try to save time by skipping steps. But skipping a pilot bioequivalence (BE) study is not always a good idea. There are situations where going directly to the pivotal study can be risky. For example, if the drug is highly variable, poorly soluble, or has ... Read More